tiprankstipranks
Trending News
More News >
Diamedica Therapeutics Inc (DMAC)
NASDAQ:DMAC
US Market
Advertisement

Diamedica Therapeutics (DMAC) Revenue

Compare
534 Followers

Diamedica Therapeutics Revenue

Diamedica Therapeutics had a revenue of 0.00 in the quarter ending Jun 30, 2025, with ―. This bring the company's revenue in the last twelve months to 13.80M, Decreased 0.00%. In the fiscal year ending Dec 31, 2024, Diamedica Therapeutics had annual revenue of 0.00 with ― growth.
Revenue (ttm)
13.80M
Revenue Growth
P/S Ratio
Revenue/Employee
$0
Employees
27
Market Cap
$361.82M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
-500.00K
Dec 31, 2018
500.00K-50,000,000.00%
Dec 31, 2017
Dec 31, 2016
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis